Clinical studies recruiting near Bari

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Instituto Tumori Giovanni Paolo II · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico · Daiichi Sankyo · NCT07022483 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · A.O.U.C. Policlinico di Bari · Bristol-Myers Squibb · NCT07106762 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · AOU Consorziale Policlinico "Aldo Moro" - UO Ematologia con · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Azienda Universitaria Ospedaliera Consorziale Policlinico Ba · Boehringer Ingelheim · NCT07355296 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Takeda · NCT07108283 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Ospedale Pediatrico Giovanni XXIII · Travere Therapeutics, Inc. · NCT06247085 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hoffmann-La Roche · NCT06793215 Randomization of Single vs Multiple Arterial Grafts
NA · Anthea Hospital · Weill Medical College of Cornell University · NCT03217006 Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · Azienda ospedaliero universitaria consorziale policlinico - · Italian Sarcoma Group · NCT04845893 Subendocardial Viability Ratio in Hypertension
Phase N/A · Unità Operativa Semplice Dipartimentale Ipertensione Arterio · Istituto Auxologico Italiano · NCT06309511 TrueLok Elevate PMCF Study
Phase N/A · Orthofix s.r.l. · NCT07079774 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Osp. "San Paolo" · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Instituto Tumori Giovanni Paolo II · Eli Lilly and Company · NCT06890598 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Takeda · NCT07244263 Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
NA · Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapi · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04587856 Atropine Eyedrops for Myopia Progression in Children and Adolescents (MODERATO STUDY)
Phase 3 · Ophthalmology - AOU Consorziale Policlinico - Ospedale Pedia · Ocus Innovation Ireland Limited · NCT07028827 Efficacy of INM004 in Children With STEC-HUS
Phase 3 · University Hospital Consorziale Policlinico · Inmunova S.A. · NCT06389474 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per · Merck Sharp & Dohme LLC · NCT06077760 Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patie
Phase N/A · University Health Network, Toronto · NCT06877598 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Istituto Tumori "Giovanni Paolo II" I.R.C.C.S. · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 Eliciting Informed Goals of Care in Elderly Patients
NA · Royal Victoria Hospital, Canada · NCT06002113 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Fundacion INTECNUS · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · IRCCS Istituto Tumori Giovanni Paolo II · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Azienda Universitaria Ospedaliera Consorziale Policlinico Ba · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
Phase N/A · Ospedale IRCCS Saverio De Bellis · Implantica CE Reflux Ltd. · NCT05870163 Prismatic Lenses and tDCS in Neglect
NA · Istituti Clinici Scientifici Maugeri · Istituti Clinici Scientifici Maugeri SpA · NCT05842551 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT03955445

Look up another city

Look up another condition